Editorial: Volume II: anti-inflammatory drug development focusing on immune mediated diseases
Frontiers in Pharmacology · 10.03.2026 · 17
DOI: 10.3389/fphar.2026.1807303 ↗Kurz gefasst
Editorial in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.03.2026. Verfasst von José Fernando Oliveira-Costa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infusions and Specialized Medicines of Bahia-CIMEB, Bahia State Health Department, Salvador, Brazil. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Infusions and Specialized Medicines of Bahia-CIMEB, Bahia State Health Department, Salvador, Brazil.
- Immune Engineering Lab, School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, Mandi, India.
- Life Science Institute, University of Michigan, Ann Arbor, MI, United States.
Zitieren
APA
Oliveira-Costa, J. F., Chaudhary, A., Rawat, S. S., & Prasad, A. (2026). Editorial: Volume II: anti-inflammatory drug development focusing on immune mediated diseases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1807303
Vancouver
Oliveira-Costa JF, Chaudhary A, Rawat SS, Prasad A. Editorial: Volume II: anti-inflammatory drug development focusing on immune mediated diseases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1807303
BibTeX
@article{OliveiraCosta2026,
author = {Oliveira-Costa, José Fernando and Chaudhary, Anubha and Rawat, Suraj Singh and Prasad, Amit},
title = {Editorial: Volume II: anti-inflammatory drug development focusing on immune mediated diseases},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1807303}
}
EUVIMED